PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1991 May; 84(5): 277–279.
PMCID: PMC1293225

Psychomotor and clinical assessment of flumazenil as an antagonist of midazolam.

Abstract

The benzodiazepine antagonist flumazenil (0.01 mg/kg) has been compared with doxapram (1 mg/kg) and saline for the reversal of anaesthesia with intravenous midazolam, alfentanil, nitrous oxide in oxygen and isoflurane. The completeness of reversal was assessed by means of a four-choice reaction time test, 1 and 3 h following the antagonist. In addition, the level of sedation was graded using a five-point scale. Psychomotor testing showed that 60 min after administration of the antagonist, there were marked increases in reaction times (P less than 0.05) both in the control and doxapram groups, but not in those receiving flumazenil. At 180 min, however, reaction times in all groups had returned to baseline values. In contrast, there was a significant difference in the sedation scores between the saline and flumazenil groups throughout the study period (P less than 0.05). During the 4 h following midazolam, there was no evidence of re-sedation in any of the groups despite the relatively high midazolam dosage.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (706K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Forster A, Morel D, Bachmann M, Gemperle M. Respiratory depressant effects of different doses of midazolam and lack of reversal with naloxone--a double-blind randomized study. Anesth Analg. 1983 Oct;62(10):920–924. [PubMed]
  • Sleigh JW. Failure of aminophylline to antagonize midazolam sedation. Anesth Analg. 1986 May;65(5):540–540. [PubMed]
  • Caldwell CB, Gross JB. Physostigmine reversal of midazolam-induced sedation. Anesthesiology. 1982 Aug;57(2):125–127. [PubMed]
  • Breimer LT, Hennis PJ, Bovill JG, Spierdijk J. The efficacy of flumazenil versus physostigmine after midazolam-alfentanil anaesthesia in man. Eur J Anaesthesiol Suppl. 1988;2:109–116. [PubMed]
  • Mitchell RA, Herbert DA. Potencies of doxapram and hypoxia in stimulating carotid-body chemoreceptors and ventilation in anesthetized cats. Anesthesiology. 1975 May;42(5):559–566. [PubMed]
  • Robertson GS, MacGregor DM, Jones CJ. Evaluation of doxapram for arousal from general anaesthesia in outpatients. Br J Anaesth. 1977 Feb;49(2):133–140. [PubMed]
  • Gupta PK, Dundee JW. Hastening of arousal after general anaesthesia with doxapram hydrochloride. Br J Anaesth. 1973 May;45(5):493–496. [PubMed]
  • Allen CJ, Gough KR. Effect of doxapram on heavy sedation produced by intravenous diazepam. Br Med J (Clin Res Ed) 1983 Apr 9;286(6372):1181–1182. [PMC free article] [PubMed]
  • Lauven PM, Schwilden H, Stoeckel H, Greenblatt DJ. The effects of a benzodiazepine antagonist Ro 15-1788 in the presence of stable concentrations of midazolam. Anesthesiology. 1985 Jul;63(1):61–64. [PubMed]
  • Ricou B, Forster A, Brückner A, Chastonay P, Gemperle M. Clinical evaluation of a specific benzodiazepine antagonist (RO 15-1788). Studies in elderly patients after regional anaesthesia under benzodiazepine sedation. Br J Anaesth. 1986 Sep;58(9):1005–1011. [PubMed]
  • Nilsson A, Persson MP, Hartvig P. Effects of the benzodiazepine antagonist flumazenil on postoperative performance following total intravenous anaesthesia with midazolam and alfentanil. Acta Anaesthesiol Scand. 1988 Aug;32(6):441–446. [PubMed]
  • Bodenham AR. Death after flumazenil. BMJ. 1989 Aug 12;299(6696):457–457. [PMC free article] [PubMed]
  • Lim AG. Death after flumazenil. BMJ. 1989 Sep 30;299(6703):858–859. [PMC free article] [PubMed]
  • Luger TJ, Morawetz RF, Mitterschiffthaler G. Additional subcutaneous administration of flumazenil does not shorten recovery time after midazolam. Br J Anaesth. 1990 Jan;64(1):53–58. [PubMed]
  • Klausen NO, Juhl O, Sørensen J, Ferguson AH, Neumann PB. Flumazenil in total intravenous anaesthesia using midazolam and fentanyl. Acta Anaesthesiol Scand. 1988 Jul;32(5):409–412. [PubMed]
  • Hindmarch I. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol. 1980 Sep;10(3):189–209. [PMC free article] [PubMed]
  • Scott WA, Whitwam JG, Wilkinson RT. Choice reaction time. A method of measuring postoperative psychomotor performance decrements. Anaesthesia. 1983 Dec;38(12):1162–1168. [PubMed]
  • Klotz U, Ziegler G, Reimann IW. Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man. Eur J Clin Pharmacol. 1984;27(1):115–117. [PubMed]
  • Allonen H, Ziegler G, Klotz U. Midazolam kinetics. Clin Pharmacol Ther. 1981 Nov;30(5):653–661. [PubMed]
  • Jensen S, Knudsen L, Kirkegaard L. Flumazenil used in the antagonizing of diazepam and midazolam sedation in out-patients undergoing gastroscopy. Eur J Anaesthesiol Suppl. 1988;2:161–166. [PubMed]
  • Marty J, Joyon D. Haemodynamic responses following reversal of benzodiazepine-induced anaesthesia or sedation with flumazenil. Eur J Anaesthesiol Suppl. 1988;2:167–171. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press